Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5709234 | The Journal of Arthroplasty | 2017 | 23 Pages |
Abstract
Preoperative ramosetron provided more prolonged PONV prophylaxis than ondansetron after TKA in our setting, and had a similar ADR profile. Other trials are needed to confirm our results before ramosetron is adopted widely.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Piya MD, Mungkorn MD, Chaivet MD, Adisai MD,